Table 4.
Risk ratios for toxicity results
| IV topotecan vs CAV1 | IV vs Oral topotecan2 | Oral topotecan vs CAV3 | |
|---|---|---|---|
| Grade 4 neutropenia | 0.98 (0.82 to 1.17) | 1.47 (1.22 to 1.78) | 0.67 (0.51 to 0.87) |
| Grade 4 thrombocytopenia | 5.83 (2.35, 14.42) | 0.70 (0.49 to 1.01) | 8.41 (3.17 to 22.35) |
| Grade 4 anaemia | 1.46 (0.25 to 8.54) | 0.60 (0.22 to 1.65) | 2.46 (0.33 to 18.53) |
1- Direct comparison (Von Pawel 1999); 2- Direct comparison (Von Pawel 2001 & Eckardt 2007); 3- Indirect comparison (Von Pawel 1999/Von Pawel 2001 & Eckardt 2007).